Brock University has signed an agreement with The Centre for Drug Research and Development (CDRD) that will allow Brock’s researchers to tap into CDRD’s drug development infrastructure and expertise.
“This agreement could not have come at a better time in Brock’s history,” says John Wilson, director of Innovation and Commercialization in the Office of Research Services.
“With the recent opening of our state-of-the-art research facilities and the development of our BioLinc program, we’re making major inroads in developing and applying our research in industry,” says Wilson. “This, in turn, creates jobs and vitality for the entire community.”
CDRD, a national, not-for-profit drug development and commercialization center, specializes in helping scientists develop discoveries that are commercially promising into new medicines and treatments.
By collaborating with CDRD, investigators gain access to project management, commercial analysis and evaluation, other research institutions, researchers working in complementary areas, and specialized scientific equipment and expertise to help get their research into the market.
“We are very pleased to extend our network to Brock University,” says Karimah Es Sabar, CDRD President and CEO. “As a national centre, it is important that we serve researchers throughout the country, and enable great discoveries such as those being made at Brock to be transformed into viable commercial opportunity.”
CDRD will be holding a workshop at Brock Thursday, Feb. 14 to explain more about its services and areas of potential partnerships.
The Centre for Drug Research and Development (CDRD) (www.cdrd.ca) provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD combines its drug development platform with a commercial arm, which licenses technologies from affiliated institutions and establishes working collaborations with other biotech and lifesciences companies. The Government of Canada’s Networks of Centres of Excellence program has recognized CDRD as a Centre of Excellence in Commercialization in Research (CECR).
About Brock University
Brock University, located in St. Catharines, Ontario, Canada, is increasingly becoming a major player in the Niagara Region’s economic, social, and cultural development. The recently-opened $112-million Cairns Family Health and Bioscience Research Complex is home to Brock’s BioLinc Business Incubator, which fosters partnerships between Brock researchers and area businesses to commercialize research innovations. The complex also contains the advanced Phytotron greenhouse, to be used for making medicines from plants and improving environmental stress in soybeans and disease resistance in rice. A key focus is on a transdisciplinary approach to research, where experts from different disciplines collaborate to create a less restricted culture for examining issues and advancing knowledge.
For more information, please contact:
Director, Innovation and Commercialization
Tel: (905) 688-5550 x4808
Research communications/media relations specialist
Tel: (905) 688-5550 x5789;
The Centre for Drug Research and Development,
Tel: (604) 827-1223